Giotrif
Active substance: afatinib
afatinib
Centralised EU authorisationActive
Marketing holder: Boehringer Ingelheim International GmbH
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 3 |
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-1931-74ed-ab11-5d948b1ee800,01a12095-25c2-7842-8c44-921d76cd3ebc,01a12097-64cf-773f-a320-112a18369610;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/002280
- Registration status
- Active
- ATC code
- L01XE13
Sources
- product · EMA · EMEA/H/C/002280 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002280 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002280 · Verified 2026-10-09